0001209191-15-029058.txt : 20150325
0001209191-15-029058.hdr.sgml : 20150325
20150325062233
ACCESSION NUMBER: 0001209191-15-029058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150320
FILED AS OF DATE: 20150325
DATE AS OF CHANGE: 20150325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yu Julie
CENTRAL INDEX KEY: 0001593352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 15723223
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-03-20
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001593352
Yu Julie
C/O AMICUS THERAPEUTICS
CRANBURY
NJ
08512
0
1
0
0
VP Clinical Ops & Data Mgmt
Common stock
2015-03-20
4
M
0
7785
11.5074
A
57785
D
Common stock
2015-03-20
4
S
0
7785
11.5074
D
50000
D
Stock Options (right to buy)
3.53
2015-03-20
4
M
0
1459
0.00
D
2014-01-28
2023-01-28
Common Stock
1459
8341
D
Stock Opitons (right to buy)
2.52
2015-03-20
4
M
0
715
0.00
D
2014-06-18
2023-06-18
Common stock
715
9026
D
Stock Options (right to buy)
2.45
2015-03-20
4
M
0
5611
0.00
D
2015-01-03
2024-01-03
Common stock
5611
39389
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.16 to $11.91. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.16 to $11.91. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Julie Yu
2015-03-25